COVID-19: Implications for Managing Antiretroviral Therapy in Patients With HIV

The DHHS released interim guidance on special considerations during the COVID-19 pandemic for patients with HIV. Here’s my take on how these can be incorporated into practice to minimize patient risk.

Paul E. Sax, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: April 10, 2020 Expired: April 9, 2021

The DHHS recently released practical guidance on maintaining stable ART for patients with HIV during the COVID-19 pandemic. Here are some considerations for implementing this guidance.

Princy N. Kumar, MD, FIDSA, MACP Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Released: April 21, 2020 Expired: April 20, 2021

The DHHS guidance on managing care for persons with HIV during the COVID-19 pandemic recommends integrating telehealth and postponing routine visits. What does this mean for patients who are not stably suppressed? Here’s my experience.

David A. Wohl, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: August 14, 2020 Expired: August 13, 2021

Are PWH at risk of more severe COVID-19 illness? How should PWH protect themselves? Here’s what we know.

Renslow Sherer, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Released: October 12, 2020 Expired: October 11, 2021